A purple and pink letter v on a white background.
June 4, 2019

Webinar Recording: Achieving Better Patient Outcomes with TriBella™

When it comes to medical aesthetic treatments, patients are always looking for solutions that not only deliver results, but that also help them save time, whether it’s through shorter treatments or fewer visits to the clinic. This is where a treatment like TriBella™ by Venus Versa™ can offer significant benefits. TriBella™ is a tri-modality treatment protocol for total skin renewal with remarkable clinical outcomes.

TriBella™ with Venus Versa™, our leading multi-platform device, is the ultimate facial rejuvenation protocol that has produced great results even just after one treatment. To help our customers learn more about the value of the treatment and the Venus Versa™ platform, we turned to Michael Gold, MD, FAAD, a renowned dermatologist and cosmetic surgeon and the founder of multiple practices in Nashville Tennessee, including the Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and the Tennessee Clinical Research Center. In this webinar, Dr. Gold discussed the profound results produced by TriBella™ treatments and what it’s done for his aesthetics business. Watch the full webinar below.

The TriBella™ Treatment

The innovative TriBella™ protocol combines three different treatments with three unique technologies in one session for synergistic improvements in patients’ skin texture, tone, and tightness . The first step is an IPL photorejuvenation treatment to target unwanted pigmentation in the skin. The second step is an anti-aging treatment with the DiamondPolar applicator , equipped with our proprietary (MP) 2 technology (Multi-Polar Radio Frequency + Pulsed Electro Magnetic Fields) to smoothen out fine lines and wrinkles while firming up lax skin. Last but not least, the Nano F ractional RF applicator for skin resurfacing is used to even out the overall texture and complexion of the skin.

In addition to helping you deliver the best treatments for your patients with cutting-edge technology, we are also committed to ensuring that your practice is financially successful, which is why we offer the industry’s first and only true subscription-based acquisition model backed by unparalleled clinical, technical, and business development support. Discover your options with Venus Concept today by contacting an expert using the button below.

By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.